➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Baxter
Boehringer Ingelheim
Johnson and Johnson
Moodys

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Sodium nitroprusside - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for sodium nitroprusside and what is the scope of patent protection?

Sodium nitroprusside is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Abraxis Pharm, Akorn, Amneal, Amphastar Pharms Inc, Baxter Hlthcare, Caplin, Cipla, Dr Reddys Labs Ltd, Medicure, Micro Labs, Mylan Labs Ltd, Nexus Pharms, Sagent Pharms Inc, Somerset Theraps Llc, Sun Pharm, Teva Parenteral, Virtus Pharm, and Exela Pharma Scs Llc, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and seventy-two drug master file entries for sodium nitroprusside. Thirteen suppliers are listed for this compound.

Drug Prices for sodium nitroprusside

See drug prices for sodium nitroprusside

Recent Clinical Trials for sodium nitroprusside

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityEarly Phase 1
Dr. Graeme SmithEarly Phase 1
Shaanxi Provincial People's HospitalPhase 1/Phase 2

See all sodium nitroprusside clinical trials

Pharmacology for sodium nitroprusside
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for sodium nitroprusside

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071555-001 Nov 16, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071961-001 Aug 1, 1988 AP RX No Yes   Start Trial   Start Trial   Start Trial
Teva Parenteral SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 073465-001 Mar 30, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Somerset Theraps Llc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 210882-001 Aug 17, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 210114-001 Apr 10, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-001 Mar 8, 2017 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKesson
Baxter
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.